Back to Dashboard

CT-P44 3.1

MM•NCT06952478•Last updated: 2/17/2026

Recruiting

Study Design

Study Drug

CT-P44+Lena+Dexa

Mechanism of Action

CD38+

Sponsor

Unknown

Design

III

Control Arm

DRd

Criteria

Inclusion Criteria

≥1 prior Tx(Including Lenalidomide )

Age: Phase: III

Exclusion Criteria

Enrollment

Progress0 / 10

Contact Information

Principal Investigator

Unknown

Study Nurse

溫上容

Contact Tel

3998